Welcome to our dedicated page for Waldencast plc SEC filings (Ticker: WALD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Waldencast plc filings document the company's foreign-issuer reporting for a beauty and wellness platform with Obagi Medical and Milk Makeup as operating brands. Form 6-K reports furnish financial results, interim consolidated financial statements, earnings-date notices, and business updates covering skincare, cosmetics, medical aesthetics, distribution, operating expenses, and brand performance.
The filing record also covers annual general meeting voting, director re-appointments, auditor ratification, credit-facility agreements, trademark transfer and coexistence agreements involving the Obagi mark in Japan, and registration-statement incorporation references. Other disclosures address the completed SEC investigation connected to prior financial restatement matters and material weaknesses in internal control over financial reporting.
Waldencast plc reported updates via a Form 6-K, noting the sale of its rights to the “Obagi” trademark in Japan and the entry into a new credit facility. The company characterized these steps as strengthening its balance sheet.
A press release dated November 14, 2025 is attached as Exhibit 99.1 for further details. The information in this report, including the exhibit, is designated as not “filed” under Section 18 of the Exchange Act.